Sativex multiple sclerosis drug

Sativex multiple sclerosis drug

C011/0050

Rights Managed

Caption

Sativex multiple sclerosis drug. Sativex is a cannabinoid oromucosal mouth spray developed by GW Pharmaceuticals for multiple sclerosis patients. It is used to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. It is also being trialled as a pain control drug for cancer patients.

Release details

Model release not required. Property release not available.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}